JeffreyLouisSugarmanMD

Dermatology • Santa Rosa, CA

Dermatologic Surgery, Pediatric Dermatology

Physician

Join to view full profile

Dr. Sugarman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sugarman's full profile

Already have an account?

Office
2725 Mendocino Ave
Santa Rosa, CA 95403
Phone+1 707-545-4537

Fax+1 707-545-6726

Education & Training

University of California (San Francisco)Residency, Dermatology, 1999 - 2002
University of WashingtonResidency, Pediatrics, 1996 - 1999
University of California San Diego School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 1999 - 2025
UT State Medical License 2018 - 2020
WA State Medical License 1996 - 1999
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2013
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis Start of enrollment: 2006 Dec 01
Completed
Phase 4
Systemic Therapies for Pediatric Atopic Dermatitis Start of enrollment: 2011 Oct 01
Recruiting
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
Completed
Phase 2
Mirvaso in Use Study Start of enrollment: 2014 Sep 01
Completed
Phase 4
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets Start of enrollment: 2018 Jan 31
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

24 citations
The epidermal barrier in atopic dermatitis.
Jeffrey L Sugarman
Seminars in Cutaneous Medicine and Surgery. 2008-06-01
8 citations
Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study
Lawrence F. Eichenfield, Boni E. Elewski, Jeffrey L Sugarman, Ted Rosen, Tracey C. Vlahovic
Journal of the American Academy of Dermatology. 2021-04-01
35 citations
Skin-infiltrating, interleukin-22–producing T cells differentiate pediatric psoriasis from adult psoriasis
Kelly M. Cordoro, Maria Hitraya-Low, Keyon Taravati, Priscila Munoz Sandoval, Esther A. Kim
Journal of the American Academy of Dermatology. 2017-09-01

Lectures

Sun Exposure Disorders and Sun Protection
10/11/2014
New Trends in the Management of Acne
10/11/2014
Lumps and Bumps in Children
10/11/2014

Press Mentions

Advances in Pediatric Eczema TreatmentJanuary 3rd, 2020
Sol-Gel Technologies Hosting Analyst & Investor DayJuly 25th, 2019
Luma Therapeutics Announces Positive Clinical Data for the Illuvinate System, a New in-Home Treatment for PsoriasisMarch 6th, 2019
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow